US 11230592
DNA antibody constructs for use against middle east respiratory syndrome coronavirus
granted A61KA61K2039/53A61K39/42
Quick answer
US patent 11230592 (DNA antibody constructs for use against middle east respiratory syndrome coronavirus) held by Inovio Pharmaceuticals, Inc. expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/53, A61K39/42